Koury, Mark J.
Haase, Volker H.
Article History
First Online: 9 June 2015
Competing interests
: M.J.K. is a consultant for Keryx Biopharmaceuticals, Inc. V.H.H. has received honoraria from Daiichi Sankyo and serves on the Scientific Advisory Board of Akebia Therapeutics, a company that develops prolyl 4-hydroxylase inhibitors for the treatment of renal anaemia.